Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic biomarker in acutely admitted patients with atrial fibrillation
Abstract Background Atrial fibrillation (AF) is associated with a higher incidence of stroke, heart failure, and mortality. Risk assessment of clinical outcomes in patients hospitalized acutely with AF remains a challenge. Purpose To investigate if soluble urokinase plasminogen activator receptor (s...
Saved in:
| Main Authors: | Frederik Dencker Wisborg, Nora Olsen El Caidi, Ida Arentz Taraldsen, Sandra Tonning, Aginsha Kandiah, Mohammed El‐Sheikh, Hashmat S. Z. Bahrami, Ove Andersen, Line Jee Hartmann Rasmussen, Jens Hove, Ulrik Dixen, Johannes Grand |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Journal of Arrhythmia |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/joa3.70077 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Significance of suPAR in glomerular diseases
by: RUAN Dong-dong, et al.
Published: (2020-01-01) -
An emerging role of inflammatory biomarker (suPAR) for prognostic evaluation of atrial fibrillation
by: Nihar Jena
Published: (2025-06-01) -
Soluble urokinase-type plasminogen activator receptor strongly predicts global mortality in acute heart failure patients: insight from the STADE-HF registry
by: Fabien Huet, et al.
Published: (2021-06-01) -
The predictive value of suPAR for glomerular segmental sclerosis lesions in renal pathology
by: Zurong Zhang, et al.
Published: (2025-12-01) -
Association of soluble urokinase plasminogen activator receptor and epidermal growth factor with histopathological findings of kidney biopsy: a single-center study
by: Eman Nagy, et al.
Published: (2025-07-01)